.svg)
Publications et nouvelles
Restez au courant des annonces de Nualtis, de la couverture de presse et des publications scientifiques. Découvrez comment nous faisons progresser la technologie des films oraux et façonnons l'avenir des soins pharmaceutiques.
LTS and Nualtis Announce Strategic Cooperation to Expand Global Manufacturing Capabilities, Accelerate Market Expansion, and Ensure Customer Success
Nualtis has consistently demonstrated success in advancing OTF technologies. As Nualtis expands its pipeline of OTF programs, the collaboration supports scalable growth while offering its partners greater supply chain flexibility and security. The collaboration provides a unique opportunity for Nualtis to strengthen its position as a leader in the OTF market.
Nualtis Announces Strategic Partnership with OrthoNu for Innovative Orthodontic Care Products
"This partnership with OrthoNu represents a significant milestone for Nualtis as we expand our presence in the OTC marketplace," said Dr. Michael Raven, Chief Executive Officer at Nualtis.
IntelGenx Announces Rebranding to Nualtis, Signaling Strategic Evolution and Renewed Vision
IntelGenx, a leader in oral thin film drug delivery, today announced its official rebrand to Nualtis, marking a pivotal step in the company’s transformation and long-term strategic vision.